International audienceImportance Presymptomatic carriers of chromosome 9 open reading frame 72 (C9orf72) mutation, the most frequent genetic cause of frontotemporal lobar degeneration and amyotrophic lateral sclerosis, represent the optimal target population for the development of disease-modifying drugs. Preclinical biomarkers are needed to monitor the effect of therapeutic interventions in this population.Objectives To assess the occurrence of cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers.Design, Setting, and Participants The PREV-DEMALS study is a prospective, multicenter, observational study of first-degree relatives of individuals carrying the C9orf72 mutation. Eighty-four participants entered...
Objective We sought to characterize C9orf72 expansions in relation to genetic ancestry and age at on...
© 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. This is an open access a...
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. T...
International audienceImportance Presymptomatic carriers of chromosome 9 open reading frame 72 (C9o...
The G4C2-repeat expansion in C9orf72 is the most common cause of frontotemporal dementia and of amyo...
International audienceOBJECTIVE:C9orf72 hexanucleotide repeats expansions account for almost half of...
Altres ajuts: This work was in part supported by the Canadian Consortium on Neurodegeneration in Agi...
International audienceOBJECTIVE. To assess the added value of neurite orientation dispersion and den...
© The Author(s) 2022. Springer Nature Switzerland AG. Part of Springer Nature. Open Access This arti...
Data Availability Statement: Data will be available on request from the authors until 2030.Supplemen...
Appendix 1: Authors. Appendix 2: Coinvestigators: Coinvestigators are listed at https://cdn-links.lw...
© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LL...
Background: Frontotemporal dementia is a heterogenous neurodegenerative disorder, with about a third...
BACKGROUND: Frontotemporal dementia is a heterogenous neurodegenerative disorder, with about a third...
The G4C2-repeat expansion in C9orf72 is the most common known cause of amyotrophic lateral sclerosis...
Objective We sought to characterize C9orf72 expansions in relation to genetic ancestry and age at on...
© 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. This is an open access a...
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. T...
International audienceImportance Presymptomatic carriers of chromosome 9 open reading frame 72 (C9o...
The G4C2-repeat expansion in C9orf72 is the most common cause of frontotemporal dementia and of amyo...
International audienceOBJECTIVE:C9orf72 hexanucleotide repeats expansions account for almost half of...
Altres ajuts: This work was in part supported by the Canadian Consortium on Neurodegeneration in Agi...
International audienceOBJECTIVE. To assess the added value of neurite orientation dispersion and den...
© The Author(s) 2022. Springer Nature Switzerland AG. Part of Springer Nature. Open Access This arti...
Data Availability Statement: Data will be available on request from the authors until 2030.Supplemen...
Appendix 1: Authors. Appendix 2: Coinvestigators: Coinvestigators are listed at https://cdn-links.lw...
© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LL...
Background: Frontotemporal dementia is a heterogenous neurodegenerative disorder, with about a third...
BACKGROUND: Frontotemporal dementia is a heterogenous neurodegenerative disorder, with about a third...
The G4C2-repeat expansion in C9orf72 is the most common known cause of amyotrophic lateral sclerosis...
Objective We sought to characterize C9orf72 expansions in relation to genetic ancestry and age at on...
© 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. This is an open access a...
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. T...